Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
In this study we hypothesize that blocking the angiotensin II AT1-receptor improves the
insulin-induced microvascular dilatation. Objectives: 1. Does blockade of the angiotensin II
AT1-receptor improve the insulin-induced microvascular effects in hypertensive patients. 2.
Does blockade of the angiotensin II AT1-receptor impair the insulin-induced microvascular
effects in normotensive control subjects?
Phase:
N/A
Details
Lead Sponsor:
Maastricht University Medical Center
Treatments:
Angiotensin II Angiotensinogen Felodipine Insulin Irbesartan